| Acne |
No |
| Active substance |
Imiquimod |
| Also known as |
Imiquimod cream |
| Aromatization |
No |
| Blood pressure |
No effect |
| Chemical name |
1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine |
| Classification |
immune response modifier (IRM) |
| Dosage (medical) |
Apply topically to the affected area as per the prescription, usually 2 to 3 times per week |
| Dosage (sports) |
Not applicable |
| Effects |
Enhances local immune response to treat skin conditions |
| Formula |
C14H16N4 |
| Half-life |
Not applicable for topical administration (systemic absorption minimal) |
| HBR |
No |
| Hepatotoxicity |
No |
| Lab Test |
None specific for monitoring Imiquimod |
| Main action |
Induces immune response through Toll-like receptor 7 (TLR7) agonism |
| Side effects |
Local skin irritation, redness, itching, flakiness, and in rare cases, systemic reactions |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Substance class |
Immune response modifier |
| Trade name |
Aldara, Zyclara |
| Use in sports |
None |
| WAREHOUSE |
International Warehouse 2 |
| Water Retention |
No |
| Manufacturer |
Meda Pharma |
